Modified experimental vaccine protects monkeys from deadly malaria
Scientists modified an existing vaccine to more closely mimic the protein complex used by the parasite.
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, modified an experimental malaria vaccine and showed that it completely protected four of eight monkeys who received it against challenge with the virulent Plasmodium falciparum malaria parasite. In three of the remaining four monkeys, the vaccine delayed when parasites first appeared in the blood by more than 25 days.
This page was last updated on Friday, January 21, 2022